Loading…
Dhanvantri Jeevan Rekha (BSE 531043)₹20.85+4.98%Healthcare Service Provider
Dhanvantri Jeevan Rekha is compared with the 10 closest in size in Healthcare Service Provider (37 companies in the industry). It has a P/E of 22.4 against a peer median of 22.4, and ROCE of 3.9% against a peer median of 0.8%, and latest-quarter sales growth of 24.1% against a peer median of 24.1%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Healthcare Service Provider
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Transgene Biotek | 19 | — | −2.4 | −17.9 | 2.04 | 0.0 | 0 | −2 | 25.0 | — | vs BSE 531043 |
| Nidan Laboratories and Healthcare | 19 | 12.4 | 6.0 | 2.5 | 0.16 | 0.0 | 26 | 2 | −11.3 | −91.0 | vs BSE 531043 |
| Looks Health Services | 13 | — | 0.2 | 0.1 | 0.00 | 0.0 | 0 | 0 | 62.5 | — | vs BSE 531043 |
| Dolphin Medical Services | 11 | 711.0 | 0.6 | 0.4 | 0.09 | 0.0 | 1 | 0 | 38.5 | — | vs BSE 531043 |
| Family Care Hospitals | 11 | — | −25.6 | −38.4 | 0.55 | 0.0 | 0 | −9 | 300.0 | — | vs BSE 531043 |
| Dhanvantri Jeevan Rekha | 9 | 22.4 | 3.9 | 3.9 | 0.00 | 0.0 | 26 | 0 | 24.1 | 675.0 | — |
| Boston Commerce | 8 | — | 0.1 | −10.3 | 0.18 | 0.0 | 0 | −1 | −100.0 | — | vs BSE 531043 |
| Clinitech Laboratory | 7 | 16.4 | 7.2 | 4.7 | 0.06 | 0.0 | 9 | 0 | 6.0 | −27.8 | vs BSE 531043 |
| Dr Lalchandani Labs | 6 | 107.8 | 0.8 | 0.5 | 0.15 | 0.0 | 4 | 0 | −8.6 | −146.2 | vs BSE 531043 |
| Ashram Online.com | 5 | — | 0.8 | −1.2 | 0.32 | 0.0 | 0 | −0 | 25.0 | — | vs BSE 531043 |
| Gian Lifecare | 4 | — | 2.4 | −0.2 | 0.31 | 0.0 | 6 | −0 | −29.7 | −73.5 | vs BSE 531043 |
| Peer median | 9 | 22.4 | 0.8 | 0.1 | 0.16 | 0.0 | 1 | 0 | 24.1 | −73.5 |
Listed companies closest to Dhanvantri Jeevan Rekha in Healthcare Service Provider include Transgene Biotek, Nidan Laboratories and Healthcare, Looks Health Services, Dolphin Medical Services, Family Care Hospitals, Boston Commerce, Clinitech Laboratory, Dr Lalchandani Labs.
Transgene Biotek, with a market cap of ₹19.10 Cr.
Dhanvantri Jeevan Rekha trades at a P/E of 22.4; the median of its peer set is 22.4. A P/E above or below the median is a description, not a judgement on value.
Dhanvantri Jeevan Rekha's return on capital employed is 3.9%, above the peer median of 0.8%.